{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:39:48Z","timestamp":1791884388638,"version":"4.3.4"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"DOI":"10.2146\/ajhp120056","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T17:00:05Z","timestamp":1345136405000},"page":"1458-1461","source":"Crossref","is-referenced-by-count":7,"title":["Bumetanide continuous-infusion dosing in critically ill pediatric patients"],"prefix":"10.1093","volume":"69","author":[{"given":"Christina F.","family":"Bulkley","sequence":"first","affiliation":[{"name":"Office of Experiential Education Department of Pharmacy College of Pharmacy University of Oklahoma Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences College of Pharmacy University of Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Henry","sequence":"additional","affiliation":[{"name":"Section of Critical Care Department of Pediatrics College of Medicine University of Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences College of Pharmacy University of Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa V.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences College of Pharmacy University of Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences College of Pharmacy University of Oklahoma P.O. Box 26901 Oklahoma City, OK 73117"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041607103106900_b1-0691458","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0009-9236(96)90197-6","article-title":"Pharmacokinetics of bumetanide in critically ill infants","volume":"60","author":"Sullivan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"2019041607103106900_b2-0691458","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0009-9236(96)90198-8","article-title":"Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants","volume":"60","author":"Sullivan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"2019041607103106900_b3-0691458","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0009-9236(96)90199-X","article-title":"Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants","volume":"60","author":"Sullivan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"2019041607103106900_b4-0691458","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/009127009803801102","article-title":"Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients","volume":"38","author":"Marshall","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"2019041607103106900_b5-0691458","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000244492","article-title":"The pharmacokinetics of bumetanide in the newborn infant","volume":"72","author":"Lopez-Samblas","year":"1997","journal-title":"Biol Neonate"},{"key":"2019041607103106900_b6-0691458","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/PCC.0b013e3181e912a7","article-title":"The use of bumetanide for oliguric acute renal failure in preterm infants","volume":"12","author":"Oliveros","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"2019041607103106900_b7-0691458","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentrations for estimating glomerular filtration rate in infants, children, and adolescents","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"2019041607103106900_b8-0691458","volume-title":"Furosemide monograph","year":"2012"},{"key":"2019041607103106900_b9-0691458","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0009-9236(96)90170-8","article-title":"Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration","volume":"60","author":"Wakelkamp","year":"1996","journal-title":"Clin Pharmacol Ther"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/17\/1458\/28455515\/ajhp1458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:21:55Z","timestamp":1555413715000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/17\/1458\/5111909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,1]]},"references-count":9,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp120056","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,9,1]]},"published":{"date-parts":[[2012,9,1]]}}}